• Alzheimer’s Disease (AD) is arguably one of the most complex and debilitating neurodegenerative diseases. It is generally characterized not only by neuroinflammation and oxidative stress, but also by the accumulation of amyloid-β and tau hyperphosphorylation. Because current treatments do not stop, reverse, or sometimes even slow the progression of the disease, more effective treatments are needed. A new study (February 2017) from Frontiers in Pharmacology, discusses how cannabidiol (CBD), which has demonstrated neuroprotective, anti-inflammatory, and antioxidant properties, is non-psychoactive and may be an effective treatment option for those struggling with...

  • One of the best advocates for the power of CBD (Cannabidiol), a non-psychotropic cannabinoid that can be found in cannabis/hemp, are players in the National Football Leage (NFL).  The athletes who participate in this sport are well aware of the need for non-addictive, natural plant-based medicines that do not have the drastic and negative side-effects that often come with opiates.  From The Cannabist: “Cannabis has been proven to be effective for managing pain, and the U.S. Department of Health and Human Services has held a patent since 2003 that suggests...

  • Preliminary research is showing that there may be some positive effects for the treatment of Alzheimer's and dementia using the phytocannabinoid CBD.  Every human is pre-wired to be responsive to cannabinoids through receptors in the Endocannabinoid System. 1- Endocannabinoid signalling in Alzheimer’s disease 2- A molecular link between the active component of marijuana and Alzheimer’s disease pathology 3- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells 4- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease 5- Cannabinoids for the treatment of...